Benzodiazepine use and risk for alzheimer disease

Journal of Clinical Psychopharmacology

Volumn 35, Issue 1, 2015, Pages 1-3

  Salzman, Carl ^a   Shader, Richard I ^b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZODIAZEPINE; CHOLINESTERASE INHIBITOR; MEMANTINE; BENZODIAZEPINE DERIVATIVE;

ALZHEIMER DISEASE; COGNITIVE DEFECT; DEMENTIA; DRUG USE; EDITORIAL; HUMAN; NERVE CELL NETWORK; PRACTICE GUIDELINE; PRESCRIPTION; PRIORITY JOURNAL; CHEMICALLY INDUCED; FEMALE; MALE;

ALZHEIMER DISEASE; BENZODIAZEPINES; FEMALE; HUMANS; MALE;

EID: 84925774662     PISSN: 02710749     EISSN: 1533712X     Source Type: Journal    
DOI: 10.1097/JCP.0000000000000247     Document Type: Editorial

References (21)

1. de Gage SB, Moride Y, Ducruet T, et al. Benzodiazepine use and risk of Alzheimer's disease: case-control study. BMJ. 2014:349:g5205.
2. Riley KP, Snowdon DA, Desrosiers MF, et al. Early life linguistic ability, late life cognitive function, and neuropathology: findings from the Nun Study. Neurobiol Aging. 2005;26:341-347.
3. The University of Minnesota's Nun Study FAQ page, 18 Dec 2009, Available at: http://www.healthstudies.umn.edu/nunstudy/faq.jsp. Accessed September 30, 2014.
4. Andreasen N, Hesse C, Davidsson P, et al. Cerebrospinal fluid beta-amyloid (1-42) in Alzheimer disease: differences between early-and late-onset Alzheimer disease and stability during the course of disease. Arch Neurol. 1999;56:673-680.
5. Chan D, Janssen JC, Whitwell JL, et al. Change in rates of cerebral atrophy over time in early-onset Alzheimer's disease: longitudinal MRI study. Lancet. 2003;362:1121-1122.
6. Reid W, Broe G, Creasey H, et al. Age at onset and pattern of neuropsychological impairment in mild early-stage Alzheimer disease. A study of a community-based population. Arch Neurol. 1996; 53:1056-1061.
7. McMurtray AM, Licht E, Yeo T, et al. Positron emission tomography facilitates diagnosis of early-onset Alzheimer's disease. Eur Neurol. 2008;59:31-37.
8. Rosenberg PB, Mielke MM, Appleby BS, et al. The association of neuropsychiatric symptoms in MCI with incident dementia and Alzheimer disease. Am J Geriatr Psychiatry. 2013;21:685-695.
9. Gallagher D, Coen R, Kilroy D, et al. Anxiety and behavioural disturbance as markers of prodromal Alzheimer's disease in patients with mild cognitive impairment. Int J Geriatr Psychiatry. 2011;26:166-172.
10. Porter VR, Buxton WG, Fairbanks LA, et al. Frequency and characteristics of anxiety among patients with Alzheimer's disease and related dementias. J Neuropsychiatry Clin Neurosci. 2003;15:180-186.
11. Kaiser NC, Liang LJ, Melrose RJ, et al. Differences in anxiety among patients with early-versus late-onset Alzheimer's disease. J Neuropsychiatry Clin Neurosci. 2014;26:73-80.
12. French SL, Floyd M, Wilkins S, et al. The Fear of Alzheimer's Disease Scale: a new measure designed to assess anticipatory dementia in older adults. Int J Geriatr Psychiatry. 2012;27:521-528.
13. McCurry SM, Gibbons LE, Logsdon RG, et al. Anxiety and nighttime behavioral disturbances. Awakenings in patients with Alzheimer's disease. J Gerontol Nurs. 2004;30:12-20.
14. Souza-Talarico JN, Chaves EC, Lupien SJ, et al. Relationship between cortisol levels and memory performance may be modulated by the presence or absence of cognitive impairment: evidence from healthy elderly, mild cognitive impairment and Alzheimer's disease subjects. J Alzheimers Dis. 2010;19:839-848.
15. Johansson L, Guo X, Waern M, et al. Midlife psychological stress and risk of dementia: a 35-year longitudinal population study. Brain. 2010;133:2217-2224.
16. Johansson L, Guo X, Duberstein PR, et al. Midlife personality and risk of Alzheimer disease and distress: a 38-year follow-up. Neurology. 2014;83:1538-1544.
17. Salzman C. Anxiety in the elderly: treatment strategies. J Clin Psychiatry. 1990;51 Suppl:18-21.
18. Madhusoodanan S, Bogunovic OJ. Safety of benzodiazepines in the geriatric population. Expert Opin Drug Saf. 2004;3:485-493.
19. Pomara N, Deptula D, Singh R, et al. Cognitive toxicity of benzodiazepines in the elderly. In: Salzman C, Lebowitz BD, eds. Anxiety in the Elderly Treatment and Research. New York, NY: Springer Publishing; 1991:175-190.
20. Salzman C, Fisher J, Nobel K, et al. Cognitive improvement following benzodiazepine discontinuation in elderly nursing home residents. Int J Ger Psychiatry. 1992;7:89-93.
21. Salzman C, ed. Clinical Geriatric Psychopharmacology. 4th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2005:449-482.